ADGI announces update for Brazil's order for dengue fever and malaria vivex test kits.STAMFORD, Conn.--(BW HealthWire)--May 16, 1997--American Diversified diversified (di·verˑ·s Group Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:ADGI) Friday announced that it has been informed by its representative for Brazil that the registration process for dengue fever dengue fever (dĕng`gē, –gā), acute infectious disease caused by four closely related viruses and transmitted by the bite of the Aedes mosquito; it is also known as breakbone fever and bone-crusher disease. test kits by the National Health Foundation of Brazil, State of Roraima, should be complete within 2-4 weeks, following which shipment of the order for 100,000 dengue fever test kits will commence. ADGI has also been informed that the malaria malaria, infectious parasitic disease that can be either acute or chronic and is frequently recurrent. Malaria is common in Africa, Central and South America, the Mediterranean countries, Asia, and many of the Pacific islands. vivex test kit manufacturer has received from the National Health Foundation the required blood samples and should complete sample malaria vivex test kits for shipment to Brazil within 30 days. Following approval, ADGI will commence shipment pursuant to an initial order for 100,000 malaria vivex test kits from the State of Roraima. ADGI is sending to Brazil for testing and approval additional malaria vivex test kits to expand its product line and accelerate the order and approval process. The potential market for dengue fever and malaria vivex test kits for ADGI in Brazil, nationally, is approximately 2 million test kits, for total sales of up to $16 million. ADGI's principal business efforts involve the marketing, sale and distribution of generic pharmaceuticals and vitamins, blood derivative derivative: see calculus. derivative In mathematics, a fundamental concept of differential calculus representing the instantaneous rate of change of a function. products, including human serum albumin Human serum albumin is the most abundant protein in human blood plasma. It is produced in the liver. Albumin comprises about half of the blood serum protein. It is soluble and monomeric. and diagnostic test kits for the international pharmaceutical export market. For further information, call Dr. Jerrold R. Hinton at 203/328-3092. CONTACT: American Diversified Group Inc., Stamford Dr. Jerrold R. Hinton, 203/328-3092 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion